186 related articles for article (PubMed ID: 33259545)
1. Risk factors of progression to endometrial cancer in women with endometrial hyperplasia: A retrospective cohort study.
Jeong JY; Hwang SO; Lee B; Kim K; Kim YB; Park SH; Choi HY
PLoS One; 2020; 15(12):e0243064. PubMed ID: 33259545
[TBL] [Abstract][Full Text] [Related]
2. New concepts for an old problem: the diagnosis of endometrial hyperplasia.
Sanderson PA; Critchley HO; Williams AR; Arends MJ; Saunders PT
Hum Reprod Update; 2017 Mar; 23(2):232-254. PubMed ID: 27920066
[TBL] [Abstract][Full Text] [Related]
3. Endometrial cancer and hyperplasia rate in women before menopause with abnormal uterine bleeding undergoing endometrial sampling.
Gawron I; Łoboda M; Babczyk D; Ludwin I; Basta P; Pityński K; Ludwin A
Przegl Lek; 2017; 74(4):139-43.. PubMed ID: 29696944
[TBL] [Abstract][Full Text] [Related]
4. PTEN expression in endometrial hyperplasia and risk of cancer: a systematic review and meta-analysis.
Raffone A; Travaglino A; Saccone G; Viggiani M; Giampaolino P; Insabato L; Mollo A; De Placido G; Zullo F
Arch Gynecol Obstet; 2019 Jun; 299(6):1511-1524. PubMed ID: 30915635
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and management of endometrial hyperplasia: A UK national audit of adherence to national guidance 2012-2020.
Henderson I; Black N; Khattak H; ; Gupta JK; Rimmer MP
PLoS Med; 2024 Feb; 21(2):e1004346. PubMed ID: 38421942
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome of postmenopausal women with non-atypical endometrial hyperplasia on endometrial sampling.
Rotenberg O; Fridman D; Doulaveris G; Renz M; Kaplan J; Gebb J; Xie X; Goldberg GL; Dar P
Ultrasound Obstet Gynecol; 2020 Apr; 55(4):546-551. PubMed ID: 31389091
[TBL] [Abstract][Full Text] [Related]
7. Risk factors of endometrial cancer in patients with endometrial hyperplasia: implication for clinical treatments.
Zhao J; Hu Y; Zhao Y; Chen D; Fang T; Ding M
BMC Womens Health; 2021 Aug; 21(1):312. PubMed ID: 34433451
[TBL] [Abstract][Full Text] [Related]
8. Absolute risk of endometrial carcinoma during 20-year follow-up among women with endometrial hyperplasia.
Lacey JV; Sherman ME; Rush BB; Ronnett BM; Ioffe OB; Duggan MA; Glass AG; Richesson DA; Chatterjee N; Langholz B
J Clin Oncol; 2010 Feb; 28(5):788-92. PubMed ID: 20065186
[TBL] [Abstract][Full Text] [Related]
9. Endometrial carcinoma risk among women diagnosed with endometrial hyperplasia: the 34-year experience in a large health plan.
Lacey JV; Ioffe OB; Ronnett BM; Rush BB; Richesson DA; Chatterjee N; Langholz B; Glass AG; Sherman ME
Br J Cancer; 2008 Jan; 98(1):45-53. PubMed ID: 18026193
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of the levonorgestrel intrauterine system (LNG-IUS) in the prevention of the atypical endometrial hyperplasia and endometrial cancer: retrospective data from selected obese menopausal symptomatic women.
Morelli M; Di Cello A; Venturella R; Mocciaro R; D'Alessandro P; Zullo F
Gynecol Endocrinol; 2013 Feb; 29(2):156-9. PubMed ID: 23134558
[TBL] [Abstract][Full Text] [Related]
11. Complexity of glandular architecture should be reconsidered in the classification and management of endometrial hyperplasia.
Travaglino A; Raffone A; Saccone G; Mollo A; De Placido G; Mascolo M; Insabato L; Zullo F
APMIS; 2019 Jun; 127(6):427-434. PubMed ID: 30802329
[TBL] [Abstract][Full Text] [Related]
12. The incidence rates of endometrial hyperplasia and endometrial cancer: a four-year population-based study.
Yuk JS
PeerJ; 2016; 4():e2374. PubMed ID: 27635340
[TBL] [Abstract][Full Text] [Related]
13. Prediction of coexistent carcinomas risks by subjective EIN diagnosis and comparison with WHO classification in endometrial hyperplasias.
Yang YF; Liao YY; Peng NF; Li LQ; Xie SR; Wang RB
Pathol Res Pract; 2012 Dec; 208(12):708-12. PubMed ID: 23044462
[TBL] [Abstract][Full Text] [Related]
14. Endometrial hyperplasia as a risk factor of endometrial cancer.
Nees LK; Heublein S; Steinmacher S; Juhasz-Böss I; Brucker S; Tempfer CB; Wallwiener M
Arch Gynecol Obstet; 2022 Aug; 306(2):407-421. PubMed ID: 35001185
[TBL] [Abstract][Full Text] [Related]
15. Endometrial hyperplasia in infertile women undergoing IVF/ICSI: A retrospective cross-sectional study.
Tian Y; Liu Y; Wang G; Lv Y; Zhang J; Bai X; Zhang H; Song X
J Gynecol Obstet Hum Reprod; 2020 Nov; 49(9):101780. PubMed ID: 32360632
[TBL] [Abstract][Full Text] [Related]
16. Risk of subsequent endometrial carcinoma associated with endometrial intraepithelial neoplasia classification of endometrial biopsies.
Lacey JV; Mutter GL; Nucci MR; Ronnett BM; Ioffe OB; Rush BB; Glass AG; Richesson DA; Chatterjee N; Langholz B; Sherman ME
Cancer; 2008 Oct; 113(8):2073-81. PubMed ID: 18720479
[TBL] [Abstract][Full Text] [Related]
17. Identifying women 45 years and younger at elevated risk for endometrial hyperplasia or cancer.
Beavis AL; Blechter B; Najjar O; Fader AN; Katebi Kashi P; Rositch AF
Gynecol Oncol; 2023 Jul; 174():98-105. PubMed ID: 37172411
[TBL] [Abstract][Full Text] [Related]
18. The usefulness of p16 and COX-2 expression on the prediction of progression to endometrial cancer.
Kalkan HE; Akman L; Serin G; Terek MC; Zekioglu O; Ozsaran AA
Histol Histopathol; 2024 May; 39(5):565-571. PubMed ID: 37503793
[TBL] [Abstract][Full Text] [Related]
19. Endometrial hyperplasia and the risk of progression to carcinoma.
Lacey JV; Chia VM
Maturitas; 2009 May; 63(1):39-44. PubMed ID: 19285814
[TBL] [Abstract][Full Text] [Related]
20. Significant risk of occult cancer in complex non-atypical endometrial hyperplasia.
Travaglino A; Raffone A; Saccone G; D'Alessandro P; Arduino B; de Placido G; Mascolo M; Insabato L; Zullo F
Arch Gynecol Obstet; 2019 Nov; 300(5):1147-1154. PubMed ID: 31531779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
